Published in Metabolism on July 01, 1996
Validation of self reported smoking by serum cotinine measurement in a community-based study. J Epidemiol Community Health (2002) 5.48
Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet (2002) 2.65
Antibiotic prophylaxis for hysterectomy, a prospective cohort study: cefuroxime, metronidazole, or both? BJOG (2013) 2.00
Changes in agonist-antagonist EMG, muscle CSA, and force during strength training in middle-aged and older people. J Appl Physiol (1985) (1998) 1.62
Time course of changes in breathing pattern in morphine- and oxycodone-induced respiratory depression. Anaesthesia (1999) 1.56
Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology (1999) 1.47
A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther (1993) 1.45
Quality of life 4 years after stroke. Stroke (1988) 1.42
The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects. Br J Clin Pharmacol (1992) 1.40
Assessment of the state-of-the-art trueness and precision of serum total-calcium and glucose measurements in Finnish laboratories--the QSL-Finland study. Scand J Clin Lab Invest (1998) 1.38
Effects of acetaldehyde on cell regeneration and differentiation of the upper gastrointestinal tract mucosa. J Natl Cancer Inst (1997) 1.30
Objectively measured tobacco exposure during pregnancy: neonatal effects and relation to maternal smoking. Br J Obstet Gynaecol (1993) 1.30
High acetaldehyde levels in saliva after ethanol consumption: methodological aspects and pathogenetic implications. Carcinogenesis (1997) 1.23
Psychomotor, respiratory and neuroendocrinological effects of buprenorphine and amitriptyline in healthy volunteers. Eur J Clin Pharmacol (1987) 1.23
Paraoxonase gene polymorphisms and coronary reactivity in young healthy men. J Mol Med (Berl) (2001) 1.21
Comparison of analgesic efficacy of oxycodone and morphine in postoperative intravenous patient-controlled analgesia. Acta Anaesthesiol Scand (1998) 1.16
The pharmacokinetics of oxycodone after intravenous injection in adults. Br J Clin Pharmacol (1991) 1.15
Low-density lipoprotein-independent effects of statins. Curr Opin Lipidol (1999) 1.14
The profile of recovery from stroke and factors influencing outcome. Stroke (1985) 1.13
Psychomotor skills during acute and two-week treatment with mianserin (ORG GB 94) and amitriptyline, and their combined effects with alcohol. Ann Clin Res (1977) 1.12
Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines. Am J Physiol Gastrointest Liver Physiol (2001) 1.11
Morphine and oxycodone in the management of cancer pain: plasma levels determined by chemical and radioreceptor assays. Pharmacol Toxicol (1990) 1.11
Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. J Pharmacol Exp Ther (2001) 1.11
Dose of midazolam should be reduced during diltiazem and verapamil treatments. Br J Clin Pharmacol (1994) 1.11
Effect of tricyclic antidepressants and alcohol in psychomotor skills related to driving. Clin Pharmacol Ther (1975) 1.10
The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens. Pharmacol Biochem Behav (1998) 1.09
Changing pattern of cerebral palsy in the southwest region of Finland. Acta Paediatr Scand (1989) 1.08
Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med (2000) 1.04
Comparison of alfentanil, fentanyl and sufentanil for total intravenous anaesthesia with propofol in patients undergoing coronary artery bypass surgery. Br J Anaesth (2000) 1.03
The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle. Am J Cardiol (1996) 1.02
Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists. J Pharmacol Exp Ther (2001) 1.02
Objectively measured tobacco exposure among pregnant women in Finland in 1986 and 1990. Acta Obstet Gynecol Scand (1994) 1.02
Pharmacokinetics and ventilatory effects of intravenous oxycodone in postoperative children. Br J Clin Pharmacol (1994) 1.02
Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin. Clin Pharmacol Ther (2007) 1.01
Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol. J Pharmacol Exp Ther (1993) 1.00
Single and repeated dose comparison of three antihistamines and phenylpropanolamine: psychomotor performance and subjective appraisals of sleep. Br J Clin Pharmacol (1981) 0.99
Adenosylmethionine decarboxylase from various organisms: relation of the putrescine activation of the enzyme to the ability of the organism to synthesize spermine. Biochem Biophys Res Commun (1976) 0.98
Effect of aluminium hydroxide and glycopyrrhonium on the absorption of ethambutol and alcohol in man. Br J Clin Pharmacol (1978) 0.97
Reduced aggression in AMPA-type glutamate receptor GluR-A subunit-deficient mice. Genes Brain Behav (2004) 0.96
Heat exposure and drugs. A review of the effects of hyperthermia on pharmacokinetics. Clin Pharmacokinet (1998) 0.96
Actions and interactions with alcohol of drugs on psychomotor skills: comparison of diazepam and gamma-hydroxybutyric acid. Arch Int Pharmacodyn Ther (1978) 0.96
Tofisopam, a novel 3,4-benzodiazepine: multiple-dose effects on psychomotor skills and memory. Comparison with diazepam and interactions with ethanol. Psychopharmacology (Berl) (1980) 0.96
Psychomotor, respiratory and neuroendocrinological effects of a mu-opioid receptor agonist (oxycodone) in healthy volunteers. Pharmacol Toxicol (1989) 0.95
Effects of alcohol on buspirone and lorazepam actions. Clin Pharmacol Ther (1982) 0.94
Effect of age on amnesia and sedation induced by flunitrazepam during local anaesthesia for bronchoscopy. Br J Anaesth (1978) 0.94
Effect of two weeks' treatment with thioridazine, chlorpromazine, sulpiride and bromazepam, alone or in combination with alcohol, on learning and memory in man. Psychopharmacologia (1975) 0.94
Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits. J Neurosci (2001) 0.94
Putrescine-insensitive S-adenosyl-L-methionine decarboxylase from Tetrahymena pyriformis. Acta Chem Scand B (1975) 0.93
Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation. Clin Pharmacol Ther (1997) 0.93
Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects. J Clin Pharmacol (1989) 0.93
Age-related morphine kinetics in infants. Dev Pharmacol Ther (1993) 0.93
Neuropsychological differentiation between normal aging, Alzheimer's disease and vascular dementia. Acta Neurol Scand (1986) 0.93
Effects of hangover on psychomotor skills related to driving: modification by fructose and glucose. Acta Pharmacol Toxicol (Copenh) (1976) 0.92
Exposure to high ambient temperature increases absorption and plasma concentrations of transdermal nicotine. Clin Pharmacol Ther (1996) 0.92
Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults. Atherosclerosis (2009) 0.91
Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone. Acta Anaesthesiol Scand (1997) 0.91
Increased kidney xanthine oxidoreductase activity in salt-induced experimental hypertension. Hypertension (1998) 0.90
Inhibition of intracolonic acetaldehyde production and alcoholic fermentation in rats by ciprofloxacin. Alcohol Clin Exp Res (1998) 0.90
Development of tolerance and cross-tolerance to the psychomotor actions of lorazepam and diazepam in man. Br J Clin Pharmacol (1983) 0.90
Pharmacokinetics of intravenous N-acetylcysteine in pre-term new-born infants. Eur J Clin Pharmacol (1999) 0.90
Characteristics of alcohol dehydrogenases of certain aerobic bacteria representing human colonic flora. Alcohol Clin Exp Res (1997) 0.89
Liposolubility and protein binding of oxycodone in vitro. Pharmacol Toxicol (1994) 0.89
Increases in hemodynamic variables and catecholamine levels after rapid increase in isoflurane concentration. Anesthesiology (1993) 0.87
A new device to measure drug-induced changes on reactive and coordinative skills of human performance. Pharmacol Toxicol (1987) 0.87
Arginine reverses ethanol-induced inflammatory and fibrotic changes in liver despite continued ethanol administration. J Pharmacol Exp Ther (2001) 0.87
The contribution of the active metabolites to the tolerance developing to diazepam in man: relationship to bioassayed serum benzodiazepine levels. Med Biol (1984) 0.86
Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory. Pharmacol Biochem Behav (1998) 0.86
Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans. Clin Pharmacol Ther (1995) 0.86
Intravenous infusion of midazolam, propofol and vecuronium in a patient with severe tetanus. Acta Anaesthesiol Scand (1988) 0.85
Serum and muscle tissue ubiquinone levels in healthy subjects. J Lab Clin Med (1995) 0.85
Effects of amitriptyline and mianserin on psychomotor skills and memory in man. Br J Clin Pharmacol (1978) 0.84
Rapid weight loss decreases serum testosterone. Int J Sports Med (2008) 0.84
Aldehyde dehydrogenase activity and acetate production by aerobic bacteria representing the normal flora of human large intestine. Alcohol Alcohol (1996) 0.84
Comparing ischaemic stroke in six European countries. The EuroHOPE register study. Eur J Neurol (2014) 0.84
Characteristics of aldehyde dehydrogenases of certain aerobic bacteria representing human colonic flora. Alcohol Alcohol (1998) 0.84
Psychomotor performance of patients with rheumatoid arthritis: cross-over comparison of dextropropoxyphene, dextropropoxyphene plus amitriptyline, indomethacin, and placebo. Pharmacol Toxicol (1988) 0.84
Midazolam as an induction agent in children: a pharmacokinetic and clinical study. Anesth Analg (1987) 0.84
Ubiquinone supplementation and exercise capacity in trained young and older men. Eur J Appl Physiol Occup Physiol (1995) 0.84
Comparison of effects and plasma concentrations of opioids between elderly and middle-aged patients after cardiac surgery. Acta Anaesthesiol Scand (2008) 0.83
Isoflurane in nitrous oxide and oxygen increases plasma concentrations of noradrenaline but attenuates the pressor response to intubation. Acta Anaesthesiol Scand (1991) 0.83
Memory and psychomotor impairment following high-dose interferon treatment in amyotrophic lateral sclerosis. Acta Neurol Scand (1985) 0.83
Grapefruit juice does not enhance the effects of midazolam and triazolam in man. Eur J Clin Pharmacol (1996) 0.83
Paraoxonase genotype modifies the effect of pravastatin on high-density lipoprotein cholesterol. Pharmacogenetics (2001) 0.83
Ingredients and contaminants of traditional alcoholic beverages in Tanzania. Trans R Soc Trop Med Hyg (1991) 0.83
Interaction of alcohol with maprotiline or nomifensine: echocardiographic and psychometric effects. Eur J Clin Pharmacol (1988) 0.83
Placental transfer and maternal midazolam kinetics. Clin Pharmacol Ther (1983) 0.82
Comparison of the analgesic effects of intrabursal oxycodone and bupivacaine after acromioplasty. J Clin Anesth (1999) 0.82
Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes. Int J Sports Med (2004) 0.82
Cerebellar GABAA receptors in two rat lines selected for high and low sensitivity to moderate alcohol doses: pharmacological and genetic studies. Alcohol (1992) 0.82
Drug abuse of Finnish male prisoners in 1995. Forensic Sci Int (1998) 0.82
The usefulness of radioreceptor assay and gas liquid chromatography in pharmacokinetic studies on midazolam. Int J Clin Pharmacol Ther Toxicol (1985) 0.82
Oxalic acid stabilizes dopamine, serotonin, and their metabolites in automated liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl (2001) 0.82
Midazolam versus atropine plus pethidine as premedication in children. Anaesthesia (1984) 0.82
Risk factors for complications of ERCP in primary sclerosing cholangitis. Endoscopy (2012) 0.82
Creatine and caffeine in anaerobic and aerobic exercise: effects on physical performance and pharmacokinetic considerations. Int J Clin Pharmacol Ther (1998) 0.81
Pharmaceutical thrombosis prophylaxis, bleeding complications and thromboembolism in a national cohort of hysterectomy for benign disease. Hum Reprod (2012) 0.81
Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors. Eur J Clin Pharmacol (1994) 0.81
Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men. Clin Genet (2001) 0.81